Meridian Bioscience Misses Estimates, Flattens Dividend

Meridian Bioscience, Inc. (VIVO) reported first quarter earnings of $0.15 per share on $37.3 million in revenue, badly missing consensus estimates. The company also made a disappointing dividend announcement. Analysts were expecting a profit of $0.19 per share and sales of $40.6 million, on average. Meridian declared a quarterly dividend of $0.19 per share, the [...]